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Effects of dexamethasone on renal and systemic acid-base metabolism.
We carried out long-term balance studies in adrenalectomized (ADX)
dogs to evaluate the effects of small amounts of a glucocorticoid steroid
with minimal mineralocorticoid potency (dexamethasone; DEX) on
renal and systemic acid-base metabolism under conditions of constant
mineralocorticoid replacement and both normal and increased systemic
acid loads. We investigated the effects of low and high dosages of
dexamethasone (0.2 mg/day [normal-DEX] vs. 0.8 mg/day [high-DEX])
before and during hydrochloric acid feeding (5 mmol/kg/day) in paired
studies on ADX dogs (N = 7) maintained on constant mineralocorticoid
replacement (deoxycorticosterone, corticosterone, aldosterone). Prior
to hydrochloric acid feeding, no differences in plasma acid-base compo-
sition were observed between the two dosages despite greater endoge-
nous acid production with the higher dosage of DEX, evidenced by
greater rates of both net acid excretion (NAE) and the excretion of
urinary anions other than chloride, bicarbonate, and phosphate (urine
anion gap). During hydrochloric acid feeding, mean plasma bicarbonate(PHCO,) decreased from 21.2 0.4 to 13.7 0.5 (normal-DEX) and from
21.1 0.4 to 15.8 0.4 mEq/liter (high-DEX). The difference in the
decrements in PHCO3 between groups was significant (P < 0.05). With
continued hydrochloric acid feeding in both groups, increasing the DEX
dosage from 0.2 to 0.8 mg/day in the normal-DEX group resulted in a
significant increase in NAE (NAE, + 161 mEq, P < 0.02) and in
PHCO3 (+3.6 0.5 mEq/liter, P < 0.01) to steady-state levels by day 10,
which were values not significantly different from those in high-DEX.
The DEX dose-related increase in NAE was greater than the corre-
sponding increase in endogenous acid production estimated from the
change in urine anion gap, and was due largely to an increase in
ammonium excretion, which, because urine pH did not decrease, could
not be attributed to increased intraluminal trapping of ammonia as a
result of more acidic tubular fluid. These studies indicate that the
severity of hydrochloric acid-induced metabolic acidosis in mm-
eralocorticoid-replete ADX dogs can be mitigated by increasing the
dosage of exogenous glucocorticoid and suggest that this acidosis
mitigating effect is mediated in part by the increased NAE associated
with the stimulation of renal ammonia production. These studies further
indicate that the rate of production of fixed acids of metabolism
increases with an increased dosage of exogenous glucocorticoid, but
that this acidosis-producing effect is more than offset by independent
stimulation of renal net acid excretion, such that metabolic acidosis is
prevented (basal condition) or if present (hydrochloric acid feeding) is
significantly ameliorated.
Effets de Ia dexaméthasone sur le métabolisme acido-basique renal et
systémique. Les etudes de bilan qui sont rapportées ont été réalisées
chez des chiens surrénalectomisés (ADX) pour évaluer les effets de
faibles quantites d'un stéroIde glucocorticoide, ayant une activité
minéralocorticoIde faible (dexaméthasone; DEX), sur le métabolisme
acido-basique renal et systémique dans des conditions de traitement
substitutif permanent de minéralocorticoides et de charge acide soit
normale soit élevée. Nous avons étudié les effets de doses de dexaméth-
asone (0,2 mg/jour; normale-DEX) ou 0,8 mg/jour (élevee-DEX) avant
et pendant l'administration d'acide chlorhydrique a raison de 5 mmol/
kg/jour dans des etudes appariées chez des chiens ADX (N = 7)
recevant un traitement substitutif par les minéralocorticoIdes (deoxy-
corticosterone acetate, corticosterone, aldosterone). Avant l'adminis-
tration d'acide chiorhydrique, il n'y avait pas de difference dans Ia
composition acido-basique du plasma selon les doses de DEX malgré
l'augmentation de production endogene d'acide sous l'effet de Ia dose Ia
plus élevée de DEX, augmentation traduite par une élévation de l'état
stationnaire d'excrétion nette d'acide (NAE) et de Ia somme des debits
d'excrétion des anions urinaires autres que le chlore, le bicarbonate et
le phosphate (trou anionique urinaire). Au cours de l'administration
d'acide chlorhydrique Ia concentration plasmatique moyenne de bicar-
bonate (PHCO3) a diminué de 21,2 0,4 a 13,7 0,5 (normale-DEX) et
de 21,1 0,4 a 15,8 0,4 mEq/litre (élevee-DEX). La difference des
diminutions de bicarbonate était significative (P < 0,05). Au cours de
l'administration prolongee d'acide chlorhydrique aux deux groupes
l'augmentation de Ia dose de DEX de 0,2 a 0,8 mg/jour dans le groupe
normale-DEX a eu pour résultat une augmentation significative de NAE
(NAE, + 161 mEq, P < 0,02) et de PHCO3 (+ 3,6 0,5 mEq/litre, P <
0,01), jusqu'a de nouveaux états stationnaires, le jour 10, non significa-
tivement différents de ceux observes dans le groupe Clevée-DEX.
L'augmentation de NAE dépendant de Ia dose de DEX a été plus
grande que l'augmentation correspondante de Ia production endogéne
d'acide estimée a partir de Ia modification du trou anionique urinaire,
elle était principalement due a une augmentation de l'excrétion d'am-
monium qui, du fait que le pH de l'urine n'a pas diminué, ne peut pas
étre attribuée a une augmentation de la captation intraluminale d'am-
monia. Ces résultats indiquent que Ia sévérité de l'acidose métabolique
déterminée par acide chlorhydrique chez les chiens ADX recevant des
minéralocorticoides peut être atténuée par l'augmentation de Ia dose de
glucocorticoIdes exogenes et suggere que cet effet d'atténuation a pour
médiateur partiel l'augmentation de NAE associée ala stimulation de Ia
production rénale d'ammonia. Ces rCsultats indiquent, de plus, que le
debit de production des acides fixes augmente en méme temps que la
dose de glucocorticoldes exogènes mais que cet effet de production
d'acidose est plus que compensé par Ia stimulation indépendante de
l'excrétion rénale nette d'acide, de telle sorte que I'acidose métabolique
est empechee (conditions basales) ou significativement améliorée au
cours de l'administration acide chlorhydrique.
Adrenal mineralocorticoid hormones with minimal glucocor-
ticoid activity stimulate renal net acid excretion such that states
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of mineralocorticoid excess result in renal metabolic alkalosis
[1, 2] and states of mineralocorticoid deficiency result in renal
metabolic acidosis [3, 4]. Long-term administration of adrenal
steroids with predominant glucocorticoid activity but with
substantial mineralocorticoid effect as well (cortisol, cortisone)
results in metabolic alkalosis and an increased excretion of
potassium and net acid [5—8]. In humans, long-term administra-
tion of adrenocorticotrophin, which is known to result in
sustained hypercortisolemia, results in hyperbicarbonatemia
and hypokalemia [9]. In Cushing's syndrome, the degree of
metabolic alkalosis is directly related to the degree of hypokale-
mia and hypercortisolemia [10]. The alkalosis-producing effect
of cortisol is believed to reflect the "mineralocorticoid" proper-
ties of the hormone inasmuch as renal tubular reabsorption of
sodium and chloride and renal secretion of potassium are
stimulated by cortisol administration [7, 8] and the administra-
tion of the mineralocorticoid antagonist spironolactone at least
partially reverses the apparent mineralocorticoid effects of
hydrocortisone and adrenocorticotrophin [6, 9].
The effects of glucocorticoid steroids that exhibit minimal
mineralocorticoid potency, such as dexamethasone or triam-
cinolone, on renal and systemic acid-base metabolism have dot
been specifically investigated. Dexamethasone has been shown
to stimulate hydrogen ion secretion in isolated urinary epithelia
of vertebrate species [11] and to stimulate renal ammonium
excretion in man [12]. Triamcinolone has been demonstrated to
increase renal ammonia production and plasma bicarbonate
concentration in rats, but its effects on net acid excretion and
plasma acidity were not assessed [13, 141. The long-term
administration of large amounts of triamcinolone in dogs stimu-
lates the endogenous production of organic acids and an in-
crease in net acid excretion sufficient to maintain normal acid-
base equilibrium [15].
The present long-term balance studies were carried out in
adrenalectomized dogs to evaluate the effects of small amounts
of glucocorticoid steroid (dexamethasone) on renal and system-
ic acid-base metabolism under conditions of constant mm-
eralocorticoid replacement and both normal and increased
systemic acid loads.
Methods
Plasma and urine acid-base and electrolyte composition was
determined in long-term balance studies in seven adrenalecto-
mized female mongrel dogs weighing 13 to 26 kg. Throughout
the studies, the dogs were fed a constant amount (30 g/kg/day)
of a low-electrolyte synthetic diet [1] homogenized with dis-
tilled water (60 mI/kg) and supplemented with specified
amounts of sodium chloride and potassium as the neutral
phosphate salt. Bilateral adrenalectomy was performed at least
I week before starting the metabolic diet. After surgery, the
adequacy of adrenalectomy was confirmed by the positive
finding of hyperkalemia and hyponatremia. Throughout all
study periods and for at least three days before initiating control
observations, each animal received in addition to the metabolic
diet s.c. injections of d-aldosterone acetate (Ciba) in sesame oil,
60 1i.g/day; deoxycorticosterone acetate (Organon) in sesame
oil, 0.15 mg/day; corticosterone (Sigma) in 95% ethanol, 3.0 mg/
day; and dexamethasone sodium phosphate (Merck, Sharp and
Dohme), 0.2 (study A) or 0.8 mg/day (study B). Studies A and B
were performed on the same animals with an interval of 9 to 49
days between studies. The lower dosage of dexamethasone was
used in the postoperative period and between studies A and B.
Each animal served as its own paired control.
We chose the 0.2-mg/day dosage of dexamethasone to be the
low dosage, which is considerably lower than the replacement
dosages (0.75 to 0.80 mg) used in dogs in previous studies [16—
19]. The corticosterone and deoxycorticosterone replacement
dosages were chosen to approximate the normal secretion rates
in dogs [20, 21]. The aldosterone replacement dosage chosen is
estimated to be the normal aldosterone requirement for dogs
[22].
In both studies, following a steady-state control period of 6 to
12 days, in which plasma and urine acid-base and electrolyte
composition were constant, hydrochloric acid (5.0 mmol/kg of
body wt) was administered in the daily diet for 4 days to all
seven dogs. In four dogs, acid feeding was continued for an
additional 12 days in both studies. In study A, the dexametha-
sone dosage was increased to 0.8 mg/day beginning on day 4 of
hydrochloric acid feeding. In study B, hydrochloric acid was
continued with no change in the dexamethasone dose. The
electrolyte supplement to the diet was identical in both studies
and consisted of sodium chloride (2.5 mmoles/kg/day) and
potassium (2.5 mEq/kg/day) as the neutral phosphate. Dogs that
failed to eat spontaneously were tube fed. Studies were termi-
nated if vomiting resulted in a cumulative loss greater than I dl.
At 9 A.M., after the dogs were fasted overnight, arterial blood
samples were obtained percutaneously, at intervals of 24 to 72
hours, in heparinized glass syringes from the femoral artery.
Urine was collected through the stainless-steel surfaces of the
metabolic cages, in which the animals were kept, into glass
bottles containing mineral oil and thymol-chloroform preserva-
tive.
Analytical procedures. All determinations were performed in
duplicate. The analytical methods used have been described in
a previous report [3]. Urine inorganic sulfate concentration was
determined by a modification of the method of Ma and Chan
[23]. Urine calcium concentration was determined by atomic
absorption spectrophotometry. The concentration of urinary
total organic acid was determined by titration of phosphate-
precipitated urine (prepared by the method of Van Slyke and
Palmer [24]) from a pH of 2.7 to 8.0 by means of a Radiometer
titrator (model 11) and an autoburette (model, ABU 1 B) con-
nected to a Radiometer pH meter (model PHM27). Net acid
excretion was calculated as the sum of the urinary ammonium
and the titratable acidity minus the bicarbonate. Unmeasured
anion concentration (anion gap) was calculated as follows:
and as
(PNa + PK) — (Pc, + PHCO3)
(UNH4 + UNa + UK) — (Uci + UHCO3 + Upo4 + UH,po4)
where the concentration of each species is expressed in mEq/
liter. Statistical significance was determined by Student's t test
[25].
Results
No significant differences in plasma acid-base composition
were observed at the two dosages of dexamethasone prior to
hydrochloric acid feeding (Table 1). The mean plasma sodium
concentration and the anion gap were significantly greater in
study B. The mean steady-state net acid excretion and urinary
anion gap were significantly greater in study B than they were in
Acid-base effects of dexamethasone 45
Table 1. Effect of dexamethasone dosage on steady-state plasma acid-base and electrolyte composition in mineralocorticoid-replete
adrenalectomized dogsa
Anion
Dog no.
Arterial H
nEq/liter
Arterial
Pco2
mmHg
PHCO3 gap Pci PNa PK
Pcreatinine
mgldl
Body wt
kgmEqiliter
Study A, 0.2-mg/day dexamethasone
134 39 32.8 20.5 13.7 106.9 136.7 4.3 0.56 14.2
159 41 34.2 20.2 15.9 108.1 139.8 4.5 0.61 18.6
165 45 37.9 20.5 18.0 106.0 140.1 4.4 0.53 24.9
197 42 35.2 20.7 13.9 107.8 137.7 4.6 0.56 13.9
198 39 36.4 22.7 17.9 103.9 139.8 4.7 0.85 15.6
200 39 35.1 22.0 16.1 104.1 137.5 4.6 0.94 19.0
203 40 35.7 21.7 16.2 105.9 139.3 4.5 0.56 20.6
Mean 41 35.3 21.2 16.0 106.1 138.7 4.5 0.66 18.1
SEM
Study B, 0.8-mg/day dexamethasone
134 40 32.1 19.6 17.2 107.8 140.1 4.4 0.43 13.0
159 42 34.0 19.7 20.2 105.0 140.7 4.2 0.56 17.9
165 42 36.7 21.7 19.9 106.4 143.9 4.1 0.46 25.5
197 42 36.6 21.3 19.3 105.8 141.9 4.4 0.50 13.2
198 40 37.1 22.6 17.6 106.3 142.1 4.3 0.68 15.0
200 40 36.3 21.9 17.4 107.1 140.3 4.5 0.70 19.7
203 42 36.9 21.1 17.0 106.9 140.6 4.4 0.51 20.7
Mean 41 35.7 21.1 18,4b 106.5 l41.4c 43b 0.55c 17.9
SEM ±1 ±0.7 ±0.4 ±0.5 ±0.3 ±0.5 ±0.1 ±0.04 ±1.7
a Each value represents the mean of 5 to 8 determinations of plasma acid-base and electrolyte composition and body weight during steady-state
control periods of 6 to 12 days' duration at each dose of dexamethasone (studies A and B) prior to hydrochloric acid feeding. Values for creatinine
concentrations represent the mean of two determinations. An interval of 9 to 49 days separated studies A and B.b P < 0.05, compared with study A.
P < 0.01, compared with study A.
study A and by virtually identical amounts (study B minus
study A) (Table 2). The difference in net acid excretion between
studies was accounted for by the difference in urinary ammoni-
urn excretion. The difference in urinary anion gap between
studies was accounted for, in part (42%), by the difference in
organic acid plus sulfate excretion. The mean urinary calcium
excretion was not significantly different. The mean urine pH
was significantly greater during study B.
In response to an identical load of hydrochloric acid (5.0
mmollkg/day) in the diet, the mean plasma bicarbonate concen-
tration decreased to a significantly greater extent when the
same animals were maintained on the lower dosage of dexa-
methasone (study B; Fig. 1), with the change in plasma bicar-
bonate (A vs. B, day 3) being —7.5 ± 0.6 vs. —5.3 ± 0.7 mEq/
liter, P < 0.05. During hydrochloric acid feeding the mean
arterial hydrogen ion concentration was significantly greater
during the lower dosage of dexamethasone (48 ± 1 vs. 46 ± 1
nEq/liter, P <0.05, day 1; 53 ± 2 vs. 51 ± 2 nEq/liter, day 4). A
subsequent increase in dexamethasone to the higher dose with
continued hydrochloric acid feeding caused the plasma bicar-
bonate concentration to significantly increase and thereby
reversed the prior downward trend (Fig. 1). The increase in
plasma bicarbonate concentration was associated with a signifi-
cant cumulative increase in net acid excretion of 161 ± 35 mEq
(P < 0.02) (days 3—5 to day 16) without a change in unmeasured
anion excretion (Fig. 1). The increase in net acid excretion was
due largely to ammonium without a reduction in urine pH. The
plasma and urinary electrolyte response to hydrochloric acid is
shown in Table 3.
Discussion
The results of the present studies in adrenalectomized dogs
maintained on constant mineralocorticoid replacement indicate
that a fourfold increase in the dosage of replacement glucocorti-
coid, administered as dexamethasone, increases net acid excre-
tion in the steady state without altering the plasma acid-base
composition. The increased rate of net acid excretion was
accounted for entirely by an increased rate of ammonium
excretion, which was not attributable to an increased luminal
trapping of ammonia secondary to increased luminal acidity
inasmuch as urine pH was significantly increased during the
administration of the high dosage of dexamethasone. This
finding indicates that the availability of cellular ammonia for
diffusion into tubular fluid is increased, possibly as a result of an
increased rate of renal ammonia production. This possibility is
consistent with the observation that the rate of directly mea-
sured ammonia production from isolated perfused rat kidney is
increased by an administration of triamcinolone [13], a steroid
with predominantly glucocorticoid or mineralocorticoid poten-
cy similar to dexamethasone [26]. To what extent increased
ammonia production reflects direct or indirect effects of the
steroid on the kidney remains to be determined. Dexametha-
sone has been reported to increase the plasma concentration of
glutamine, the major renal ammoniagenic precursor [12]. Nei-
ther potassium depletion nor systemic acidosis, factors known
to stimulate renal ammoniagenesis [27], were present during the
administration of the higher dosage of dexamethasone in the
present studies.
Despite the significantly greater net acid excretion rate
observed with the administration of the higher dosage of
dexamethasone, the plasma bicarbonate concentration was not
significantly different from that observed with the lower dose of
dexamethasone (Tables 1 and 2), and there was no trend in the
daily values of plasma bicarbonate concentration with either
dosage in the basal state (Fig. 1). This finding suggests that the
higher dosage of dexamethasone resulted in corresponding
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Table 2. Effect of dexamethasone dosage on steady-state urinary acid-base and electrolyte composition in mineralocorticoid-replete
adrenalectomized dogsa
Dog no. pH
TAcaic TA,1, NH4
Net
acidcai. TA
Net
acid,1, TA Na
mEqlday
Study A, 0.2-mg/day dexamethasone
134 6.20 24.6 25.6 36.2 58.8 59.7 45.7
159 5.64 36.1 39.2 43.9 79.8 82.9 48.7
165 5.81 49.3 51.5 52.5 101.5 103.7 73.5
197 5.62 30.1 31.7 31.0 61.0 62.5 39.3
198 5.84 30.6 35.5 28.9 59.1 64.1 45.7
200 5.84 33.8 36.2 35.0 68.3 70.7 59.0
203 6.07 39.6 45.5 62.9 100.8 106.7 67.0
Mean 5.86 34.9 37.9 41.5 75.6 78.6 54.1
SEM
Study B, 0.8-mg/day dexamethasone
134 6.34 20.6 23.0 52.6 69.4 71.9 46.2
159 5.88 36.6 40.2 62.4 98.6 102.2 48.8
165 6.13 43.7 49.6 75.4 117.1 123.0 78.0
197 6.00 27.0 30.5 44.8 71.1 74.6 42.6
198 6.04 28.2 29.6 37.4 65.0 66.5 34.0
200 5.93 38.5 42.4 41.7 79.7 83.6 61.1
203 6.11 36.2 38.7 59.0 93.7 96.2 61.3
Mean 6.06C 33.0 36.3 53.3" 84.9" 88.3" 53.1
SEM
+0.20C
Change, study B minus study A
118b +9.3" +9.7"
Abbreviations used are OA, organic acids; TAcaic, calculated TA based on phosphate excretion and ionic strength correction for pKa
phosphate; TA", TA by titration method; net acid, TA, net acid based on TAca,c; net acid,, TA, net acid based on TA,,. Each value represents the
mean of 6 to 12 daily determinations of urinary acid-base, electrolyte, and nitrogen excretion during the steady-state control periods at each dose of
dexamethasone (studies A and B) prior to hydrochloric acid feeding. An interval of 9 to 49 days separated studies A and B.
b P < 0.05, compared with study A.
P < 0.01, compared with study B.
increases in the net daily systemic load of hydrogen ion
destined for renal excretion (endogenous acid production) and
in the set point of renal regulation of plasma bicarbonate. If
endogenous acid production had been unchanged by the higher
dosage of dexamethasone, a significantly greater plasma bicar-
bonate concentration would have been expected in comparison
with that observed with the lower dosage owing to the increase
in net renal input of bicarbonate to the systemic circulation that
is coupled to an increase in net acid excretion [281. But the in-
ferred increase in endogenous acid production would have been
expected to cause a decrease in plasma bicarbonate concentra-
tion if the set point for renal regulation of plasma bicarbonate
concentration had not concomitantly been increased.
Consistent with the possibility that the rate of endogenous
acid production was increased by the higher dose of dexametha-
sone is the observation that the urinary excretion of anions
other than bicarbonate, phosphate, and chloride (that is, anion
gap) increased significantly (Table 2). The increase in urine
anion gap was essentially identical to that of ammonium and net
acid excretion (Table 2). The close correspondence of the
increase in urinary anion gap and ammonium suggests that the
anion gap consists of conjugate bases that were generated in the
body coupled to hydrogen ions, for example, the "so-called"
fixed acids of metabolism. At least in part, such increased
endogenous acid production was accounted for by the increased
production of sulfuric and organic acids, inasmuch as approxi-
mately 42% of the increase in anion gap was accounted for by
the measured increase in sulfate and organic acid excretion.
The factors responsible for preventing a decrease in plasma
bicarbonate concentration and pH with the higher dosage of
dexamethasone despite an apparently greater rate of endoge-
nous acid production require further consideration. It is known
from studies of chronic mineral acid feeding in dogs that the
magnitude of the chronic reduction in plasma bicarbonate
concentration and pH is determined in part by the chemical
identity of the conjugate base (anion) of the acid administered.
In the case of nitric acid feeding, plasma acid-base composition
remains unchanged despite large increases in net systemic acid
load [29]. It has been proposed that the magnitude of the steady-
state reduction in plasma bicarbonate concentration during acid
loading is directly related to the renal tubular reabsorbability of
the acid anion administered, which determines (1) the magni-
tude of urinary losses of sodium and consequent stimulation of
distal nephron avidity for sodium-hydrogen "exchange" and (2)
the facility with which the increment in filtered anion load is
delivered to terminal segments of the nephron where the
accompanying cation is reabsorbed in exchange for hydrogen
ion excreted in buffered form [291. An additional possibility to
account for the unchanged plasma bicarbonate concentration
with the higher dosage of dexamethasone is that the magnitude
of the increase in systemic acid load, an increment of approxi-
mately 10%, was insufficient to result in an appreciable reduc-
tion in plasma bicarbonate concentration, regardless of the
identity of the associated anion or anions. An additional possi-
bility to be considered is that dexamethasone directly stimu-
lates renal acid excretion and that the increment in dexametha-
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Table 2. continued
K Cl Ca OA + so4
iPO.
mmol/day
N2
g/day
Anion
gap
mEqiday
Volume
mi/daymEq/day
Study A, 0.2-mg/day dexamethasone
36.1 42.9 0.19 36.3 41.5 6.2 23.0 901
43.6 53.4 0.23 42.3 49.7 9.3 29.5 1089
67.7 70.4 0.70 63.7 71.9 11.8 44.9 1642
37.3 38.5 0.94 31.4 41.3 6.8 25.6 813
42.0 44.2 0.54 40.8 43.4 8.0 24.6 896
43.4 57.5 1.01 79.1 48.5 10.4 26.1 904
66.6 66.6 1.22 66.8 63.2 12.7 53.9 1061
48.1 53.4 0.69 51.5 51.4 9.3 32.5 1044
Study B, 0.8-mg/day dexamethasone
36.2 45.2 0.21 45.1 38.7 7.0 37.1 959
45.7 47.2 0.38 61.0 53.6 10.0 49.8 1158
65.1 72.0 0.51 70.5 72.0 15.0 60.0 1729
37.1 40.6 0.48 66.8 41.7 9.2 35.9 899
41.9 33.7 0.41 36.0 42.7 8.1 30.6 890
53.6 59.7 0.31 47.3 56.5 11.2 32.3 1013
57.0 59.9 0.52 60.1 58.6 10.4 46.1 980
48.1 51.2 0.40 55.3 52.0 10.1 4l.7! 1090
Change, study B minus study A
+9.2"
3.4
Dexamethasone DexamethasoneStudy A 0.2 mg/day 0.8 mg/day
Study B - Dexamethasone 0.8 mg/day
22
ontrol HCI, 5.0 mmoIes/kgj
20
HC03 18
mEq//iter 16
14
Net acid
excretion
mEq/day
Unmeasured
anion
excretion
mEq/day
Net renal
HCO3 input
(study A —
study B), mEq
Time, days
Fig. 1. Systemic and renal acid-base response to long-term hydrochlo-
ric acid feeding in mineralocorticoid-replaced adrenaiectomized dogs
maintained on 0.2 or 0.8 mg of dexamethasone per day (study A vs.
study B). In study A, the dexamethasone dosage was increased from 0.2
to 0.8 mg/day on day 4 of hydrochloric acid feeding. Daily net renal
bicarbonate input to the systemic circulation was calculated as the
difference between the change in () net acid excretion and unmea-
sured anion excretion (change from control) (see discussion).
sone dosage was sufficient to increase net acid excretion pan
passu with the increase in endogenous acid production. The
extent to which the dexamethasone-dependent stimulation of
renal acid excretion is attributable to direct and indirect effects
of dexamethasone on the kidney requires further investigation.
The occurrence of a dexamethasone-dependent stimulation
of renal acid excretion was further investigated by comparing
the renal and systemic acid-base response to an experimental
increase in the systemic load of hydrogen ion in paired studies
in the same animals on two different dosages of dexamethasone.
The results of these studies indicate that a significantly greater
degree of metabolic acidosis develops in response to hydrochlo-
ric acid loading during administration of the lower dosage of
dexamethasone (study A).' Furthermore, a subsequent increase
in dexamethasone dosage to the higher level used in study B
stimulated net acid excretion sufficiently to significantly in-
crease plasma bicarbonate concentration to levels similar to
those in study B. The increase in net acid excretion that
occurred when the dose of dexamethasone was increased
during hydrochloric acid feeding was accounted for largely by
the increased ammonium excretion unaccounted for by a lower-
ing of urine pH. Urine pH in fact increased as ammonium
excretion increased, suggesting that an increase in ammonia
production occurred. To relate the increase in net acid excre-
tion accompanying the increase in dexamethasone dosage to a
'Although the rapidity and severity of the development of acidosis in
study A precluded prolongation of the lower dose of dexamethasone, it
has been demonstrated that plasma bicarbonate concentration does not
increase above day-3 values with indefinite prolongation of acid feeding
over a wide range of hydrochloric acid loads (3 to 7 mmol/kg) [29].
80
1120
40
—6 —4 —2 0 2 4 6 8 10 12 14 16
net increase in renal bicarbonate input to the systemic circula-
tion, we "corrected" the values of net acid excretion for any
associated increase in endogenous acid production by subtract-
ing the daily change in anion gap from the daily change in net
acid excretion (Fig. 1). This index of net renal bicarbonate input
to the systemic circulation in comparing study A with study B
shows that, with the lower dosage of dexamethasone, the more
severe acidosis that occurred was associated with a lesser
cumulative renal input of bicarbonate, and that with the in-
crease in dexamethasone dosage, the subsequent reversal of the
progressively worsening degree of acidosis was associated with
a large increase in renal bicarbonate input.
The results of these studies do not permit inferences about
the role of endogenous glucocorticoid steroids in the regulation
of renal and systemic acid-base metabolism. Both plasma
corticosterone (rats) and cortisol (dogs) concentrations have
been observed to increase following mineral acid loading [30,
311. In the rat, the increase in plasma corticosterone level in
response to acid feeding can be prevented by prior hypophysec-
tomy, a maneuver that also prevents the increase in urinary
ammonium excretion that ordinarily occurs during acid feeding
[311. These results have led to the suggestion that, in the rat, the
renal ammonium excretory response to acid loading is depen-
dent on the increased adrenal secretion of ACTH-responsive
steroids, secondary to stimulation of the pituitary gland by
acidosis [31]. The results of the present studies are consistent
with this possibility and suggest a need for additional studies
designed to investigate the role of endogenous glucocorticoid
steroids in the regulation of acid-base homeostasis.
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